Urokinase Plasminogen Activator Receptor‐Associated Protein ( uPARAP ) as a Potential Next Generation Molecular Target for Treatment of Gastrointestinal Stromal Tumors ( GIST )

Documenti analoghi

• Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma
  di: Fabian Artusa, et al.
  Pubblicazione: (2025)
• The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Indicator of Mortality in Pediatric Septic Shock
  di: Caner Turan, et al.
  Pubblicazione: (2024)
• The Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Predictive Tool in Hospitalised Patients With Community‐Acquired Pneumonia (CAP)
  di: Lisa Hessels, et al.
  Pubblicazione: (2025)
• Serum Pepsinogen as a Biomarker of Gastrointestinal Stromal Tumors (GIST) in Stomach
  di: Zhiying Gao, et al.
  Pubblicazione: (2025)
• A Cyclic Peptide‐Based Radiotheranostic Agent for Urokinase‐Type Plasminogen Activator in Tumors
  di: Xingkai Wang, et al.
  Pubblicazione: (2025)